| mRNA |
bafilomycin A1 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.9 |
| mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0047 |
0.9 |
| mRNA |
BRD-K86535717 |
CTRPv2 |
pan-cancer |
AAC |
0.0098 |
0.9 |
| mRNA |
GW843682X |
CTRPv2 |
pan-cancer |
AAC |
0.0046 |
0.9 |
| mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0046 |
0.9 |
| mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
-0.004 |
0.9 |
| mRNA |
BRD-K01737880 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.9 |
| mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
0.0043 |
0.9 |
| mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.004 |
0.9 |
| mRNA |
BRD-K34099515 |
CTRPv2 |
pan-cancer |
AAC |
0.0087 |
0.9 |